Primary sources ClinicalTrials.gov, phase 2 topical GHK-Cu study FDA, Is It a Cosmetic, a Drug, or Both
Hypokalaemia represents a potentially serious complication during the initial treatment of severe megaloblastic anaemia, as rapid cell production depletes potassium stores
While it effectively bypasses digestion, it introduces higher costs and safety risks compared to oral or topical alternatives
However, its synthetic derivative has been shown in clinical studies to be of benefit to other organ systems in small doses
Cerebrolysin helps improve focus, slow cognitive decline, and support long-term brain function by boosting cellular regeneration and mitochondrial efficiency
First-born children are at a higher risk of developing AR